Auburn Hills, MI, United States of America

Harald Krispin

This inventor holds 1 USPTO granted patent. Top assignee: Evonik Degussa Gmbh. Active years: 2017.


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Harald Krispin in Biotechnological Methods

Introduction

Harald Krispin is an accomplished inventor based in Auburn Hills, MI (US). He has made significant contributions to the field of biotechnology, particularly in the production of valuable chemical compounds.

Latest Patents

Krispin holds a patent for a biotechnological method for producing butanol and butyric acid. The patent describes a method that involves contacting an aqueous medium containing acetogenic bacterial cells with syngas. The mixture is then incubated at a temperature between 0 and 100°C for at least 30 minutes. The aqueous medium must also contain ethanol and/or acetate at a total combined concentration of at least 0.1 g/L. This innovative approach has the potential to enhance the efficiency of producing C4 bodies.

Career Highlights

Harald Krispin is currently associated with Evonik Degussa GmbH, a leading company in specialty chemicals. His work focuses on developing sustainable methods for chemical production, which aligns with the growing demand for environmentally friendly processes.

Collaborations

Krispin has collaborated with notable colleagues, including Liv Reinecke and Dirk Weuster-Botz. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Harald Krispin's contributions to biotechnology, particularly through his patented methods, highlight his role as a key innovator in the field. His work not only advances scientific knowledge but also supports the development of sustainable practices in chemical production.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…